Given that ER-positive status is strongly associated with good outcome in breast cancer [12, 17, 18], the patient partition produced by the ROI95 is strongly prognostic (log-rank P < 0.0001, Fig. 1d). This evidence concerns the gene ESR1 and breast carcinoma.